Literature DB >> 16148606

Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension.

Toshio Imanishi1, Chizu Moriwaki, Takuzo Hano, Ichiro Nishio.   

Abstract

OBJECTIVES: Recent studies have revealed an association between coronary risk factors and both the number and function of bone marrow-derived endothelial progenitor cells (EPCs). Although hypertension is an important coronary risk factor, the influence to the EPCs is not fully understood. We investigated the effect of hypertension on EPC senescence.
METHODS: Experimental study We investigated the number and senescence of EPCs in spontaneously hypertensive rats (SHR/Izm) and deoxycorticosterone acetate (DOCA)-salt hypertensive rats. EPCs were isolated from peripheral blood of rats and were characterized. EPC senescence was detected by acidic beta-galactosidase staining. In addition, we measured the telomerase activity using polymerase chain reaction-enzyme-linked immunosorbent assay. CLINICAL STUDY: EPCs were isolated from peripheral blood samples in 37 patients with essential hypertension. After ex-vivo cultivation, we detected senescence and measured the telomerase activity. The total severity index of hypertension-induced organ damage was calculated by the summation of each severity index in the classification of hypertension severity by Tokyo University (1984).
RESULTS: Experimental study The EPC senescence in SHR/Izm and DOCA-salt hypertensive rats was significantly increased compared with that of control rats. The telomerase activities in SHR/Izm and DOCA-salt hypertensive sensitive rats were also significantly lowered compared with those of control rats. Clinical study Compared with the control group, EPCs from hypertensive patients showed accelerated senescence and also showed reduced telomerase activity. In hypertensive patients, the degree of hypertension-induced organ damage was negatively correlated with telomerase activity, and was positively correlated with EPC senescence.
CONCLUSIONS: EPC senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension, which may be related to telomerase inactivation. The hypertension-induced EPC senescence may affect the process of vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148606     DOI: 10.1097/01.hjh.0000183524.73746.1b

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  65 in total

Review 1.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

Review 2.  Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells.

Authors:  Sangho Lee; Young-Sup Yoon
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

3.  Role of the renin angiotensin system on bone marrow-derived stem cell function and its impact on skeletal muscle angiogenesis.

Authors:  Micheline M de Resende; Timothy J Stodola; Andrew S Greene
Journal:  Physiol Genomics       Date:  2010-05-25       Impact factor: 3.107

Review 4.  Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.

Authors:  Jasenka Zubcevic; Monica M Santisteban; Teresa Pitts; David M Baekey; Pablo D Perez; Donald C Bolser; Marcelo Febo; Mohan K Raizada
Journal:  Hypertension       Date:  2014-03-31       Impact factor: 10.190

5.  Preserved endothelial progenitor cell angiogenic activity in African American essential hypertensive patients.

Authors:  Seo Rin Kim; Alfonso Eirin; Sandra M S Herrmann; Ahmed Saad; Luis A Juncos; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2018-03-01       Impact factor: 5.992

6.  Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia.

Authors:  Carol Lin; Augustine Rajakumar; Daniel A Plymire; Vivek Verma; Nina Markovic; Carl A Hubel
Journal:  Am J Hypertens       Date:  2009-06-04       Impact factor: 2.689

7.  Changes in number and biological function of endothelial progenitor cells in hypertension disorder complicating pregnancy.

Authors:  Yan Zhou; Jianwen Zhu; Li Zou; Juan Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

8.  Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age.

Authors:  Christian Jung; Nicole Fischer; Michael Fritzenwanger; Hansjörg Thude; Markus Ferrari; Marlen Fabris; Bernhard R Brehm; Dagmar Barz; Hans R Figulla
Journal:  Clin Res Cardiol       Date:  2008-11-25       Impact factor: 5.460

9.  Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 2: Pharmacological targets, agents and intervention perspectives.

Authors:  C Qian; R G Schoemaker; W H van Gilst; B Yu; A J M Roks
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

10.  Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence.

Authors:  Jun Chen; Houwei Li; Francesco Addabbo; Fung Zhang; Edward Pelger; Daniel Patschan; Hyeong-Cheon Park; Mei-Chuan Kuo; Jei Ni; Glenda Gobe; Praveen N Chander; Alberto Nasjletti; Michael S Goligorsky
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.